Chimin Health Management Co., Ltd. (SHSE: 603222)
Health Care · Pharmaceuticals · CN
CN¥8.07
-2.42% today · -26.5% 1Y
Chimin Health Management Co., Ltd. (SHSE: 603222) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $617.71M and employs 1,890 people.
Over the last twelve months the share price has lost 26.5%, trading between 6.95 and 12.36.
Tweenvest scores Chimin Health Management Co., Ltd. across four factors: quality 62/100, value 36/100, growth 0/100. Its strongest factor is quality.
603222 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $617.71M
- Revenue (TTM)
- $96.74M
- P/E
- —
- EPS
- -0.48
- Dividend yield
- —
- Beta (5Y)
- 0.39
- 52-week high
- CN¥12.36
- 52-week low
- CN¥6.95
- Avg volume (3M)
- —
- Shares outstanding
- 513.45M
- Employees
- 1,890
- Next earnings
- —
About Chimin Health Management Co., Ltd.
Chimin Health Management Co., Ltd., formerly known as Zhejiang Chimin Pharmaceutical Co.,Ltd., is a Chinese enterprise specializing in the research, production, and distribution of pharmaceuticals for human use and medical apparatus. Its product offerings include diverse medical packaging options, such as non-PVC soft bags with various valve configurations (e.g., double-tube double valves, single valves, single-tube double valves), plastic bottles, and other specialized containers. The company also supplies an extensive array of injection and infusion devices, encompassing safety syringes, safety injection needles, sterile syringes, irrigators, dispensers, insulin syringes, as well as standard and precision filter infusion sets. Beyond these, Chimin Health Management provides in-vitro diagnostic products, hemodialysis supplies, and delivers medical services. The firm was established in 1996 and maintains its principal operations in Huangyan, China.
- ISIN
- CNE100002193
- Founded
- 1996
- Listed since
- Feb 17, 2015
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Chong Kun Dang Pharmaceutical Corp.KOSE: A185750 | $637.89M | ₩65,200.00 | +0.46% |
| Henan Taloph Pharmaceutical Stock Co.,LtdSHSE: 600222 | $633.29M | CN¥7.89 | -1.74% |
| Wuhan Hvsen Biotechnology Co.,Ltd.SZSE: 300871 | $630.42M | CN¥21.10 | +1.01% |
| LanZhou Foci Pharmaceutical Co.,Ltd.SZSE: 002644 | $628.82M | CN¥8.26 | +1.47% |
| TTY Biopharm Company LimitedTPEX: 4105 | $615.87M | NT$78.90 | +0.77% |
| Jianmin Pharmaceutical Group Co.,Ltd.SHSE: 600976 | $614.25M | CN¥26.86 | +0.22% |
| Shanghai New World Co., LtdSHSE: 600628 | $613.33M | CN¥6.36 | +1.27% |
| Newland Pharmaceutical Co., Ltd.SZSE: 301277 | $611.98M | CN¥10.47 | +2.25% |
Figures last refreshed Oct 4, 2026.